{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:57:29Z","timestamp":1760785049839,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies targeting components of the postsynaptic membrane of the neuromuscular junction (NMJ), leading to neuromuscular transmission deficiency. In the vast majority of patients, these autoantibodies target the nicotinic acetylcholine receptor (nAChR), a heteropentameric ion channel anchored to the postsynaptic membrane of the NMJ. Autoantibodies in patients with MG may target all the subunits of the receptor at both their extracellular and intracellular regions. Here, we combine immunoadsorption with a cell-based assay to examine the specificity of the patients' autoantibodies against the extracellular part of the nAChR. Our results reveal that these autoantibodies can be divided into distinct groups, based on their target, with probably different impacts on disease severity. Although our findings are based on a small sample group of patients, they strongly support that additional analysis of the specificity of the autoantibodies of patients with MG could serve as a valuable tool for the clinicians' decision on the treatment strategy to be followed.<\/jats:p>","DOI":"10.3389\/fneur.2022.858998","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:18:11Z","timestamp":1648599491000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria","family":"Michail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Zouvelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Belimezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Haroniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Zouridakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Zisimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: Subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/14737175.2018.1491310","article-title":"Advances in autoimmune myasthenia gravis management","volume":"18","author":"Wang","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2004-829585","article-title":"Pathophysiology of myasthenia gravis","volume":"24","author":"Hughes","year":"2004","journal-title":"Semin Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Prim."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/mus.10294","article-title":"Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro","volume":"27","author":"Skeie","year":"2003","journal-title":"Muscle Nerve."},{"key":"B16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2249.1990.tb05440.x","article-title":"Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin","volume":"82","author":"Aarli","year":"1990","journal-title":"Clin Exp Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrn731","article-title":"Ion channel structure: emerging structure of the Nicotinic Acetylcholine receptors","volume":"3","author":"Karlin","year":"2002","journal-title":"Nat Rev Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/neu.10153","article-title":"The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences","volume":"53","author":"Le Nov\u00e8re","year":"2002","journal-title":"J Neurobiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jmb.2004.12.031","article-title":"Refined structure of the nicotinic acetylcholine receptor at 4A resolution","volume":"346","author":"Unwin","year":"2005","journal-title":"J Mol Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-5728(87)90092-0","article-title":"Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor","volume":"15","author":"Tzartos","year":"1987","journal-title":"J Neuroimmunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1073\/pnas.77.2.755","article-title":"Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits","volume":"77","author":"Tzartos","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J Neuroimmunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jneuroim.2007.07.018","article-title":"Extracellular domains of the \u03b2, \u03b3 and \u03b5 subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency","volume":"190","author":"Kostelidou","year":"2007","journal-title":"J Neuroimmunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1002\/mus.27177","article-title":"Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis","volume":"63","author":"Zouvelou","year":"2021","journal-title":"Muscle Nerve."},{"key":"B26","doi-asserted-by":"publisher","first-page":"0108327","DOI":"10.1371\/journal.pone.0108327","article-title":"Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients","volume":"9","author":"Kordas","year":"2014","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0140-6736(95)92652-6","article-title":"Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen","volume":"346","author":"Vincent","year":"1995","journal-title":"Lancet."},{"key":"B28","first-page":"345","article-title":"Expression of acetylcholine receptor isoforms at extraocular muscle endplates","volume":"37","author":"Kaminski","year":"1996","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12264-012-1256-0","article-title":"Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis","volume":"28","author":"Shi","year":"2012","journal-title":"Neurosci Bull."},{"key":"B30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.410410404","article-title":"Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis","volume":"41","author":"MacLennan","year":"1997","journal-title":"Ann Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jns.2010.10.023","article-title":"Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China","volume":"301","author":"Yang","year":"2011","journal-title":"J Neurol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","article-title":"A sensitive non-isotopic assay for acetylcholine receptor autoantibodies","volume":"364","author":"Hewer","year":"2006","journal-title":"Clin Chim acta."},{"key":"B34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0165-5728(84)90065-1","article-title":"A practical enzyme immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis","volume":"6","author":"Furukawa","year":"1984","journal-title":"J Neuroimmunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u201cseronegative\u201d myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain."},{"key":"B36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14737159.2021.1927715","article-title":"Improving laboratory diagnostics in myasthenia gravis","volume":"21","author":"Gastaldi","year":"2021","journal-title":"Expert Rev Mol Diagn."},{"key":"B37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.expneurol.2015.01.011","article-title":"Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases","volume":"270","author":"Rodriguez Cruz","year":"2015","journal-title":"Exp Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1749-6632.2012.06789.x","article-title":"Antibodies identified by cell-based assays in myasthenia gravis and associated diseases","volume":"1274","author":"Vincent","year":"2012","journal-title":"Ann N Y Acad Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","article-title":"Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of Seronegative Myasthenia Gravis","volume":"72","author":"Rodr\u00edguez Cruz","year":"2015","journal-title":"JAMA Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"577403","DOI":"10.1016\/j.jneuroim.2020.577403","article-title":"Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays","volume":"349","author":"Yan","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archneurol.2012.437","article-title":"Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis","volume":"69","author":"Jacob","year":"2012","journal-title":"Arch Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in \u201cseronegative\u201d myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0193723","DOI":"10.1371\/journal.pone.0193723","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: autoantibody profiles and clinical features","volume":"13","author":"Park","year":"2018","journal-title":"PLoS ONE."},{"key":"B44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pediatrneurol.2019.01.016","article-title":"Cell-based versus enzyme-linked immunosorbent assay for the detection of acetylcholine receptor antibodies in Chinese Juvenile Myasthenia Gravis","volume":"98","author":"Yan","year":"2019","journal-title":"Pediatr Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"666046","DOI":"10.3389\/fimmu.2021.666046","article-title":"A stable cell line expressing clustered AChR: a novel cell-based assay for Anti-AChR antibody detection in Myasthenia Gravis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"10193","DOI":"10.1038\/srep10193","article-title":"Clinical application of clustered-AChR for the detection of SNMG","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Rep."},{"key":"B47","doi-asserted-by":"publisher","first-page":"26980","DOI":"10.1074\/jbc.M110731200","article-title":"Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding","volume":"277","author":"Psaridi-Linardaki","year":"2002","journal-title":"J Biol Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1111\/j.1742-4658.2006.05363.x","article-title":"Expression and characterization of soluble forms of the extracellular domains of the \u03b2, \u03b3 and \u03b5 subunits of the human muscle acetylcholine receptor","volume":"273","author":"Kostelidou","year":"2006","journal-title":"FEBS J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.10.002","article-title":"Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor \u03b1-subunit. Development of an antigen-specific therapeutic strategy","volume":"159","author":"Psaridi-Linardaki","year":"2005","journal-title":"J Neuroimmunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1196\/annals.1405.017","article-title":"Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera","volume":"1132","author":"Tzartos","year":"2008","journal-title":"Ann N Y Acad Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2016.12.011","article-title":"Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains","volume":"303","author":"Lazaridis","year":"2017","journal-title":"J Neuroimmunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0165-5728(03)00209-1","article-title":"Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis","volume":"140","author":"Feferman","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneuroim.2019.04.001","article-title":"False-positive acetylcholine receptor antibody results in patients without myasthenia gravis","volume":"332","author":"Maddison","year":"2019","journal-title":"J Neuroimmunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.nmd.2006.05.015","article-title":"Fetal arthrogryposis and maternal serum antibodies","volume":"16","author":"Dalton","year":"2006","journal-title":"Neuromuscul Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.858998\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:18:14Z","timestamp":1648599494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.858998\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":54,"alternative-id":["10.3389\/fneur.2022.858998"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.858998","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"article-number":"858998"}}